Nyhet -

The combination between biochemical and cell based assay- Attana appears in International Trade News

Long before pharmaceutical substances are tried on animals or human beings, they are carefully tested in simulated environments. Attana's biosensors characterizes  molecular interactions exactly as they would occur in the human body, the company offers its clients relevant information before further tests are carried out. To read the full article follow the link below or open the attached document.

“Our products are used for tests
which are carried out before further
trials are carried out on human
beings or animals,” confirms
company founder and CEO
Teodor Aastrup.

Relaterade länkar

Ämnen

  • Vetenskap, teknik

Kategorier

  • biochemical assay
  • cell based assays
  • biosensor
  • attana cell 200
  • international trade news
  • teodor aastrup
  • qcm
  • label free

Relaterat innehåll

  • Biosensor- Attana Cell 200, label free, real time kinetics on cells

    Revolutionary Swedish invention can potentially improve drug development! Attana AB introduces the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug development a step closer to the body.

  • Attana appears in Swedish Life Science

    "Swedish Life Science is a comprehensive introduction to an industry that employs some 40,000 people in Sweden, accounts for 20 per cent of Swedish net export worth over over SEK 40 billion, and is fast becoming a cornerstone of the national economy."

  • En ny Generation av Cell-Biosensorer för cancer-forskning

    Läs artikeln i det senaste numret av  IPT (Innovations in Pharmaceutical technologies) om nya generationens cell-biosensorer som möjliggör studier  av molekylära interaktioner direkt på celler och på så sätt indikerar rätt läkemedelskandidater i ett tidigare skede inför bland annat cancer-forskning. Att få fram en bra biologiskt anpassad modell som denna med hjälp av en cell-biosensor minskar kost

  • A New Generation of Cell-Biosensors targeting Cancer

    Read the latest article in IPT (Innovations in Pharmaceutical Technology) about the new generation cell-biosensors that enables studies in a more relevant cellular environment to better understand drug-cell interactions for development of new pharmaceuticals. A model like this using bio-sensors could significantly reduce the costs and time-scales involved in the development of the next generation